UCSF

Introduction.  The aims of this study were to characterize particle size in a thirdhand smoke aerosol and measure the effects of controlled inhalational exposure to thirdhand smoke on biomarkers of tobacco smoke exposure, inflammation and oxidative stress in human subjects Secondhand cigarette smoke changes physically and chemically after release into the environment.  Some of the resulting chemicals persist indoors as thirdhand cigarette smoke.  Thirdhand smoke that is sorbed to surfaces can emit particles back into the air.

Methods.  Smoke particle size was measured with a scanning mobility particle sizer/condensation particle counter. Using a crossover study design, 18 healthy nonsmokers received a three-hour inhalational exposure to thirdhand smoke and to filtered, conditioned air.  Thirdhand smoke was generated with a smoking machine and aged overnight in a chamber. The chamber was flushed with clean air to create the THS aerosol.  The tobacco smoke metabolites cotinine, 3-hydroxycotinine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) were measured in urine. Vascular endothelial growth factor and interleukin-6 in plasma, and 8-isoprostane in urine, were measured using enzyme-linked immunosorbent assay kits. 

Results.  Mean smoke particle size increased with aging (171 nm to 265 nm). We found significant increases in urinary cotinine and 3-hydroxycotinine after three hours of exposure to thirdhand smoke and no significant increases in NNAL, interleukin-6, vascular endothelial growth factor or 8-isoprostane.

Conclusions.  Acute inhalational exposure to 22-hour old tobacco smoke aerosol caused increases in the metabolites of nicotine but not the metabolites of the tobacco-specific nitrosamine NNK  (4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone).  This corroborates the utility of cotinine and NNAL for secondhand and thirdhand smoke exposure screening.